advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (89)
Showing records 26 to 50
Display all abstracts in classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation
71287 Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studiesBisht R
Journal of Controlled Release 2017; 248: 96-116
71551 The physical properties of generic latanoprost ophthalmic solutions are not identicalKoch Jensen P
Acta Ophthalmologica 2017; 95: 370-373
71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degenerationChen G
Journal of Controlled Release 2017; 247: 153-166
71542 Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for GlaucomaChang JY
Advanced materials (Deerfield Beach, Fla.) 2017; 29:
71312 Sustained-Release Delivery System of a Slow Hydrogen Sulfide Donor, GYY 4137, for Potential Application in GlaucomaSingh S
AAPS PharmSciTech 2017; 18: 2291-2302
71416 Nimodipine Ophthalmic Formulations for Management of GlaucomaAbd-Elgawad AH
Pharmaceutical Research 2017; 34: 809-824
71548 PLGA Nanoparticles as Subconjunctival Injection for Management of GlaucomaGhorab M
AAPS PharmSciTech 2017; 18: 2517-2528
71498 Sustained Release of Brimonidine from a New Composite Drug Delivery System for Treatment of GlaucomaDai Z
ACS applied materials & interfaces 2017; 9: 7990-7999
71287 Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studiesRupenthal ID
Journal of Controlled Release 2017; 248: 96-116
71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degenerationLi J
Journal of Controlled Release 2017; 247: 153-166
71526 Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive MicroparticlesKim SN
International Journal of Pharmaceutics 2017; 522: 66-73
71312 Sustained-Release Delivery System of a Slow Hydrogen Sulfide Donor, GYY 4137, for Potential Application in GlaucomaOpere C
AAPS PharmSciTech 2017; 18: 2291-2302
71542 Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for GlaucomaReina-Torres E
Advanced materials (Deerfield Beach, Fla.) 2017; 29:
71633 Six month delivery of gdnf from plga/vitamin e biodegradable microspheres after intravitreal injection in rabbitsCheca-Casalengua P
European Journal of Pharmaceutical Sciences 2017; 103: 19-26
71521 Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucomaKessal K
Toxicology in Vitro 2017; 41: 21-29
71416 Nimodipine Ophthalmic Formulations for Management of GlaucomaSoliman OA
Pharmaceutical Research 2017; 34: 809-824
71478 In vivo Pharmacological Evaluations of Pilocarpine-Loaded Antioxidant-Functionalized Biodegradable Thermogels in Glaucomatous RabbitsLai JY
Scientific reports 2017; 7: 42344
71548 PLGA Nanoparticles as Subconjunctival Injection for Management of GlaucomaMahmoud AA
AAPS PharmSciTech 2017; 18: 2517-2528
71529 Topical medication instillation techniques for glaucomaWu M
Cochrane Database of Systematic Reviews 2017; 2: CD010520
71417 Optimizing novel penetration enhancing hybridized vesicles for augmenting the in-vivo effect of an anti-glaucoma drugMansour S
Drug Delivery 2017; 24: 99-108
71499 Efficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucomaBell K
PLoS ONE 2017; 12: e0171636
71312 Sustained-Release Delivery System of a Slow Hydrogen Sulfide Donor, GYY 4137, for Potential Application in GlaucomaDash A
AAPS PharmSciTech 2017; 18: 2291-2302
71548 PLGA Nanoparticles as Subconjunctival Injection for Management of GlaucomaAbdel Hady M
AAPS PharmSciTech 2017; 18: 2517-2528
71416 Nimodipine Ophthalmic Formulations for Management of GlaucomaEl-Dahan MS
Pharmaceutical Research 2017; 34: 809-824
71521 Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucomaRiancho L
Toxicology in Vitro 2017; 41: 21-29
Issue 18-3
Change Issue
advertisement